Figure 4. Relative expression fold change of CDH1 at three different treatment times (A: 24h, B: 48h, and C: 72h). Gene expression results are normalized to β-actin mRNA amplification. A: * vs. control (p=0.007); # vs. 50nM (p=0.05); Ø vs. 200nM (p=0.01); B: * vs. control (p=0.01); # vs. 50nM (p=0.05); C: * vs. control (p=0.008); # vs. 50nM (p=0.01); D: CDH1 expression process within each group through study course; control (* vs. 24h (p=0.008), # vs. 24h (p=0.004)); 50nM (Ø vs. 24h (p=0.005), ϒ vs. 24h (p=0.007)); 100nM (** vs. 24h (p=0.000)); 200nM (α vs. 24h (p=0.000), β vs. 48h (p=0.01)).